Jacob S. Sherkow

New York Law School

Associate Professor

185 West Broadway

New York, NY 10013

United States

http://www.nyls.edu/faculty/faculty-profiles/faculty_profiles/jacob-s-sherkow/

Columbia University - Department of Health Policy and Management

600 West 168th Street, 6th Floor

New York, NY 10032

United States

Center for Advanced Studies in Biomedical Innovation Law

Studiestraede 6

Studiestrade 6

Copenhagen, DK-1455

Denmark

http://jura.ku.dk/cebil/staff/

SCHOLARLY PAPERS

35

DOWNLOADS
Rank 13,791

SSRN RANKINGS

Top 13,791

in Total Papers Downloads

2,962

CITATIONS

0

Scholarly Papers (35)

1.

What If Extinction is Not Forever?

Science, Vol. 340, pp. 32-33, April 2013, Stanford Public Law Working Paper No. 2298798
Number of pages: 2 Posted: 27 Jul 2013
Jacob S. Sherkow and Henry T. Greely
New York Law School and Stanford Law School
Downloads 237 (71,019)

Abstract:

Loading...

2.

The Future of Gene Patents and the Implications for Medicine

173 JAMA Internal Medicine 1569, Sept. 2013
Number of pages: 2 Posted: 15 Sep 2013 Last Revised: 25 Sep 2013
Jacob S. Sherkow and Henry T. Greely
New York Law School and Stanford Law School
Downloads 137 (146,020)

Abstract:

Loading...

gene, genetic, patent, intellectual property, myriad, amp, medicine, BRCA, cancer

3.

The Natural Complexity of Patent Eligibility

Iowa Law Review, Vol. 99, p. 1137, 2014, Stanford Public Law Working Paper No. 2268180
Number of pages: 60 Posted: 22 May 2013 Last Revised: 03 Mar 2014
Jacob S. Sherkow
New York Law School
Downloads 135 (145,298)

Abstract:

Loading...

patent, nature, law, phenomena, product, complexity, decomposition, localization, multiprong, multifactor, science, technology, intellectual property

4.

Administrating Patent Litigation

Washington Law Review, Vol. 90, p. 205, 2015, NYLS Legal Studies Research Paper No. 13/14 #84
Number of pages: 65 Posted: 26 Aug 2014 Last Revised: 14 May 2015
Jacob S. Sherkow
New York Law School
Downloads 134 (139,562)

Abstract:

Loading...

patent, admin, administrative, agencies, litigation, FTC, FCC, FDA, PTO

5.

Negativing Invention

Brigham Young University Law Review, Vol. 2011, pp. 1091-1138, 2011
Number of pages: 48 Posted: 24 Feb 2011 Last Revised: 10 Nov 2011
Jacob S. Sherkow
New York Law School
Downloads 105 (199,704)

Abstract:

Loading...

patent, invention, analogous art, negativing, technology, obviousness

6.

Patent Infringement as Criminal Conduct

Michigan Telecommunications and Technology Law Review, Vol. 19, p. 1, 2012, Stanford Public Law Working Paper No. 2022067
Number of pages: 42 Posted: 15 Mar 2012 Last Revised: 19 Dec 2012
Jacob S. Sherkow
New York Law School
Downloads 102 (192,422)

Abstract:

Loading...

patent, criminal law, crime, infringement, inducement, technology, intent, global-tech, willful blindness

7.

23andMe, the Food and Drug Administration, and the Future of Genetic Testing

174 JAMA Internal Medicine E1-E2 (2014), Stanford Public Law Working Paper No. 2402877
Number of pages: 2 Posted: 01 Mar 2014
Patricia J. Zettler, Jacob S. Sherkow and Henry T. Greely
Georgia State University - College of Law, New York Law School and Stanford Law School
Downloads 95 (187,823)

Abstract:

Loading...

23andMe, genes, genetics, genetic testing, DTC, FDA, biotech, sequencing, DNA, health, law, science

8.

A Call for the End of the Doctrine of Realignment

Michigan Law Review, Vol. 107, No. 3, p. 525, 2008
Number of pages: 36 Posted: 03 Dec 2008 Last Revised: 10 Nov 2011
Jacob S. Sherkow
New York Law School
Downloads 62 (271,465)

Abstract:

Loading...

jurisdiction, diversity, realignment, federal courts, civil procedure, alignment, party alignment, joinder, indianapolis, chase national bank

9.

Federal Trade Commission v. Actavis, Inc. and Reverse-Payment or Pay-for-Delay Settlements

Nature Biotechnology, Vol. 31, p. 316, 2013, Stanford Public Law Working Paper No. 2296187
Number of pages: 2 Posted: 20 Jul 2013 Last Revised: 26 Feb 2014
Jacob S. Sherkow
New York Law School
Downloads 54 (307,988)

Abstract:

Loading...

antitrust, patent, intellectual property, settlement, pharmaceutical, biotechnology

10.

Myriad Stands Alone

Nature Biotechnology, Vol. 32, p. 620, 2014, NYLS Legal Studies Research Paper No. 13/14 #83
Number of pages: 1 Posted: 26 Aug 2014
Jacob S. Sherkow and Christopher Thomas Scott
New York Law School and Baylor College of Medicine - Center for Medical Ethics and Health Policy
Downloads 47 (267,490)

Abstract:

Loading...

myriad, gene, genetics, patent, intellectual property, biotechnology, supreme court

11.

Law, History and Lessons in the CRISPR Patent Conflict

Nature Biotechnology, Vol. 33, pp. 256-57, March 2015, NYLS Legal Studies Research Paper No. 2579609
Number of pages: 2 Posted: 17 Mar 2015
Jacob S. Sherkow
New York Law School
Downloads 41 (192,422)

Abstract:

Loading...

intellectual property, patent, biotech, biotechnology, crispr, genetics

12.

Preliminary Injunctions Post-Mayo and Myriad

Stanford Law Review Online, Vol. 67, pp. 1-8, 2014
Number of pages: 8 Posted: 13 Jun 2014
Jacob S. Sherkow
New York Law School
Downloads 41 (332,542)

Abstract:

Loading...

patents, biosciences, law, preliminary injunctions, civil procedure, litigation, mayo, myriad, supreme court, patentable subject matter, patent eligibility, section 101

13.

And How: Mayo v. Prometheus and the Method of Invention

Yale Law Journal Online, Vol. 122, p. 351, 2013, Stanford Public Law Working Paper No. 2296033
Number of pages: 8 Posted: 21 Jul 2013 Last Revised: 02 Aug 2013
Jacob S. Sherkow
New York Law School
Downloads 41 (315,696)

Abstract:

Loading...

patent, mayo, prometheus, invention, innovation, pto, intellectual property

14.

Stem Cell Patents after the America Invents Act

Cell Stem Cell, Vol. 16, pp. 461-464, 2015
Number of pages: 4 Posted: 15 May 2015
Jacob S. Sherkow and Christopher Thomas Scott
New York Law School and Baylor College of Medicine - Center for Medical Ethics and Health Policy
Downloads 18 (305,353)

Abstract:

Loading...

patents, intellectual property, ip, AIA, PTO, cell, stem cell, bioscience, biotechnology, law, biogatekeeper, consumer watchdog, scotus, supreme court

15.

The Science of Substitution: A Response to Carrier and Minniti

University of Illinois Law Review Online (2018 Forthcoming)
Number of pages: 12 Posted: 03 Jan 2018
Jacob S. Sherkow
New York Law School
Downloads 0 (421,216)

Abstract:

Loading...

16.

Patent Protection for CRISPR: An ELSI Review

Journal of Law and the Biosciences, Vol. 4 (2017) [lsx036]
Number of pages: 12 Posted: 03 Jan 2018
Jacob S. Sherkow
New York Law School
Downloads 0 (508,714)

Abstract:

Loading...

CRISPR, patent, ELSI, science, collaboration, license, bioethics, competition, technology, genetics

17.

CRISPR, Cancer, and Collaboration in Law and STEM

Northwestern University Law Review Online, Vol. 112 (2017)
Number of pages: 3 Posted: 26 Dec 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (518,906)

Abstract:

Loading...

CRISPR, cancer, law, stem, interdisciplinary, collaboration

18.

Key Challenges in Bringing CRISPR-Mediated Somatic Cell Therapy into the Clinic

Genome Medicine, 2017
Number of pages: 4 Posted: 18 Oct 2017
University of Tasmania, Georgetown University Law Center, University of Oxford - Centre for Health, Law and Emerging Technologies, New York Law School, University of Tasmania - Faculty of Law, University of Tasmania, University of Alberta - Faculty of Public Health, University of Tasmania, University of Tasmania - Faculty of Law, University of Manchester - Centre for Social Ethics and Policy, University of Tasmania, Swinburne University of Technology, University of New South Wales (UNSW), Flinders University, University of Tasmania, University of Tasmania, University of Cambridge - Faculty of Law, Addgene, Osaka, Dept of Biomedical Ethics & Public Policy, Graduate School of Medicine, McGill University, Kyoto University, University of Western Australia, The University of Sydney, University of Tasmania, Geisinger Health System Inc. - Bioethics Research and University of Tasmania
Downloads 0 (466,891)

Abstract:

Loading...

Genome Editing, CRISPR, Somatic Cell Therapy, Genetic Diseases, Gene Therapy

19.

Patent Protection for Microbial Technologies

FEMS Microbiology Letters, Vol. 364 [fnx205], 2017, NYLS Legal Studies Research Paper No. 3041221
Number of pages: 6 Posted: 25 Sep 2017 Last Revised: 27 Dec 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (341,411)

Abstract:

Loading...

Patents; CRISPR; Virus; AMR; Incentives; Intellectual Property

20.

Patent Pools for CRISPR Technology — Response

Science, Vol. 355(6331), pp. 1274-1275 (2017)
Posted: 28 Jun 2017 Last Revised: 15 Jul 2017
Jorge L. Contreras and Jacob S. Sherkow
University of Utah - S.J. Quinney College of Law and New York Law School

Abstract:

Loading...

crispr, licensing, biotechnology, intellectual property, patents, pools, mpegla, genetics

21.

Inventive Steps: The CRISPR Patent Dispute and Scientific Progress

EMBO Reports, Vol. 18, pp. 1047-1050 (2017)
Number of pages: 5 Posted: 28 Jun 2017 Last Revised: 27 Dec 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (518,906)

Abstract:

Loading...

patent, nonobviousness, invention, crispr, science, biotechnology, intellectual property, ipr, broad, berkeley, doudna, zhang, charpentier, licensing

22.

CRISPR, Surrogate Licensing, and Scientific Discovery

Science, Vol. 355, Issue 6326, pp. 698-700, Feb. 2017, University of Utah College of Law Research Paper No. 223
Number of pages: 4 Posted: 28 Jun 2017 Last Revised: 16 Aug 2017
Jorge L. Contreras and Jacob S. Sherkow
University of Utah - S.J. Quinney College of Law and New York Law School
Downloads 0 (323,866)

Abstract:

Loading...

Intellectual Property, Patent, Biotech, Biotechnology, CRISPR, Genetics, Surrogate, Licensing, Spinoff

23.

Patents, Promises, and Reproducibility

Georgetown Journal of International Law, Vol. 49, 2018, Forthcoming
Number of pages: 19 Posted: 31 Mar 2017 Last Revised: 06 Sep 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (421,216)

Abstract:

Loading...

patent, science, reproducibility, enablement, promise doctrine, industrial application, intellectual property, Canada, Europe

24.

Cancer's IP

North Carolina Law Review, 2018, Vol. 96, pp. 297-380, NYLS Legal Studies Research Paper No. 2928241
Number of pages: 84 Posted: 07 Mar 2017 Last Revised: 18 Jan 2018
Jacob S. Sherkow
New York Law School
Downloads 0 (182,282)

Abstract:

Loading...

Patent, Science, Cancer, Drugs, Pharmaceuticals, Information Policy, Privacy, Data-Sharing, Intellectual Property, Clinical Trials, Moonshot, Public-Private Partnerships

25.

Who Owns Gene Editing? Patents in the Time of CRISPR

Biochemist, Vol. 38, p. 26 (2016), NYLS Legal Studies Research Paper No. 2915853
Number of pages: 4 Posted: 16 Feb 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (186,692)

Abstract:

Loading...

intellectual property, patent, biotech, biotechnology, crispr, genetics

26.

The Rise of the Ethical License

35 Nature Biotechnology 22 (2017)
Number of pages: 3 Posted: 13 Jan 2017 Last Revised: 16 Aug 2017
Baylor College of Medicine, Baylor College of Medicine, New York Law School and Baylor College of Medicine - Center for Medical Ethics and Health Policy
Downloads 0 (482,544)

Abstract:

Loading...

patent, license, CRISPR, gene drives, NIPT, ethics, Broad Institute, Monsanto

27.

Protecting Products versus Platforms

Nature Biotechnology, Vol. 34, pp. 462-65, NYLS Legal Studies Research Paper No. 2789281
Number of pages: 4 Posted: 05 Jun 2016
Jacob S. Sherkow
New York Law School
Downloads 0 (315,696)

Abstract:

Loading...

patents, trade secrets, intellectual property, biotechnology, startups

28.

The Changing Life Science Patent Landscape

Nature Biotechnology, vol. 34, pp. 292-93, Duke I&E Research Paper No. 2016-31
Number of pages: 3 Posted: 05 Jun 2016
Arti K. Rai and Jacob S. Sherkow
Duke University School of Law and New York Law School
Downloads 0 (366,727)

Abstract:

Loading...

patents, intellectual property, ip, AIA, PTO, bioscience, biotechnology, law, scotus, supreme court

29.

Pursuit of Profit Poisons Collaboration

Nature, vol. 532, pp. 172-173, NYLS Legal Studies Research Paper No. 2789283
Number of pages: 2 Posted: 05 Jun 2016 Last Revised: 13 Feb 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (493,113)

Abstract:

Loading...

CRISPR, Cas9, patent, science, research, commercialization, technology, biotechnology, collaboration

30.

Describing Drugs: A Response to Professors Allison and Ouellette

Duke Law Journal Online, Vol. 65, pp. 127-147, 2016
Number of pages: 21 Posted: 17 May 2016
Jacob S. Sherkow
New York Law School
Downloads 0 (445,871)

Abstract:

Loading...

patents, intellectual property, ip, PTO, drugs, pharmaceuticals, bioscience, biotechnology, law, Allison, Ouellette, written description, 112, empirical, doctrinal

31.

Patent Law's Reproducibility Paradox

Duke Law Journal, Vol. 66, pp. 845-911 (2017)
Number of pages: 67 Posted: 22 Feb 2016 Last Revised: 23 Jan 2017
Jacob S. Sherkow
New York Law School
Downloads 0 (153,668)

Abstract:

Loading...

patent, science, reproducibility, drugs, pharmaceuticals, enablement, utility, intellectual property, clinical tests

32.

The History of Patenting Genetic Material

Annual Review of Genetics, Vol. 49, p. 161, 2015
Number of pages: 22 Posted: 11 Jan 2016
Jacob S. Sherkow and Henry T. Greely
New York Law School and Stanford Law School
Downloads 0 (120,323)

Abstract:

Loading...

33.

Letter to U.S. Senate Committee on the Judiciary Concerning Inter Partes Review and Orange Book-Listed Patents

Letter to the U.S. Senate Committee on the Judiciary, 2015
Number of pages: 3 Posted: 29 Jun 2015 Last Revised: 14 Jan 2016
Arti K. Rai and Jacob S. Sherkow
Duke University School of Law and New York Law School
Downloads 0 (233,565)

Abstract:

Loading...

patent, admin, administrative, agencies, litigation, FDA, PTO, IPR

34.

CRISPR, Patents, and the Public Health

Yale Journal of Biology and Medicine, vol. 90, pp. 667-672 (2017)
Posted: 03 Jan 2018
Jacob S. Sherkow
New York Law School
Downloads 19

Abstract:

Loading...

crispr, patents, public health, gene editing, drug pricing, insurance, research, regulation, law, policy

35.

Intellectual Property, Surrogate Licensing, and Precision Medicine

IP Theory (forthcoming 2018)
Number of pages: 18
Jacob S. Sherkow and Jorge L. Contreras
New York Law School and University of Utah - S.J. Quinney College of Law
Downloads 0

Abstract:

Loading...

intellectual property, patents, licenses, precision medicine, CRISPR, biologics, drugs